Home / Pharmaceutical company intelligence
Pharmaceutical company intelligence
Bristol Mayer Biotech Pakistan
Private pharmaceutical and nutraceutical manufacturer · Lahore · Pakistan
Lahore-based pharmaceutical, biotechnology and nutraceutical manufacturer with domestic manufacturing and healthcare-product operations.
Sourced corporate profile
Corporate identity fields are source-tracked; portfolio, price and competitor intelligence remains independently calculated by MedInfoBase.
Company participation
Represent this company?
Companies may submit official corporate details, corrections and supporting documents. Independent MedInfoBase calculations remain clearly separated from company-supplied content.
Claim / verify profile →
Regulatory & corporate identity
Company profile
Public-source profile
Legal / official name Bristol Mayer Biotech Pakistan (Pvt.) Ltd.
Company type Private pharmaceutical and nutraceutical manufacturer
Address 73-B, Guldasht Town, Zarrar Shaheed Road, Lahore 54000, Pakistan · 54000
Phone +92 321 5171711
Profile details checked 16 Aug 2026
Corporate profile completeness 100%
DRAP-linked licence identifiers Shown as recorded in linked source rows; not a claim of current validity.
DSL
05-352-0068-109282D
3 linked products · source seen 12 Aug 2026
View source ↗
Location intelligence
Company location Google Maps
⌖
Location recorded
A Google Maps embed has not yet been configured for this recorded location.
Open in Google Maps ↗
Intelligence snapshot
Portfolio at a glance
Not sales data · current MedInfoBase database view
Rx 3 product presentations
G 3 generic molecules
DF 1 dosage-form groups
TA 1 therapeutic areas
PKR 3 current price records
REG 3 registration numbers
Data coverage
How complete is this profile?
Current price coverage 100%
products with a current official price
Source-linked coverage 100%
products linked back to a source record
Unit-price parse coverage 100%
priced packs safely normalized per unit
Comparable-market coverage 67%
products with at least one like-for-like comparator
Therapeutic classification 67%
products assigned to a broad therapeutic area
Visual intelligence
Downloadable company intelligence charts
Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.
Shareable intelligence
Therapeutic Portfolio Mix
⧉ Copy
↓ PNG
Shows where the company portfolio is concentrated across broad therapeutic areas.
Therapeutic Portfolio Mix Bristol Mayer Biotech Pakistan Share of current product presentations by broad therapeutic area MedInfoBase • medinfobase.com Source profile: medinfobase.com/company/bristol-mayer-biotech-pakistan Generated 19 Aug 2026 Reproductive & genitourinary 2 · 67% Unclassified 1 · 33% Percentages are based on current product presentations in the MedInfoBase company portfolio.
Portfolio distribution, not sales or market-share data.
Shareable intelligence
Dosage Form Portfolio
⧉ Copy
↓ PNG
Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.
Dosage Form Portfolio Bristol Mayer Biotech Pakistan Distribution of current product presentations by normalized dosage form MedInfoBase • medinfobase.com Source profile: medinfobase.com/company/bristol-mayer-biotech-pakistan Generated 19 Aug 2026 3 presentations Tablet 3 · 100% Dosage-form wording is normalized for intelligence display; original source wording remains preserved in product records.
Counts are product presentations, not production or sales volumes.
Shareable intelligence
Equivalent Price Position
⧉ Copy
↓ PNG
Shows whether safely comparable products are below, near or above the peer median unit price.
Equivalent Price Position Bristol Mayer Biotech Pakistan Current company products compared with like-for-like equivalent medicines using normalized unit prices MedInfoBase • medinfobase.com Source profile: medinfobase.com/company/bristol-mayer-biotech-pakistan Generated 19 Aug 2026 2 comparable products Below peer median 2 · 100% Near peer median 0 · 0% Above peer median 0 · 0% Company median price position -50.9% Lowest-price equivalents 2 Method: same generic + stated strength + dosage form + compatible unit basis; pack prices normalized per unit.
This is price-position intelligence, not sales, demand or market-share data.
Shareable intelligence
Closest Portfolio Competitors
⧉ Copy
↓ PNG
Highlights other manufacturers with the greatest generic overlap with this company portfolio.
Closest Portfolio Competitors Bristol Mayer Biotech Pakistan Companies with the largest number of shared generic medicines in the MedInfoBase database MedInfoBase • medinfobase.com Source profile: medinfobase.com/company/bristol-mayer-biotech-pakistan Generated 19 Aug 2026 Zafa Pharmaceutical Laboratories (P… 2 shared 67% overlap Aspin Pharma 2 shared 67% overlap Nabiqasim Industries (Pvt) Ltd., 1 shared 33% overlap M/s. Genix Pharma (Pvt) Ltd. 1 shared 33% overlap Atco Laboratories Limited 1 shared 33% overlap Macter International Limited 1 shared 33% overlap Portfolio overlap measures shared generics only; it is not a measure of market share, affiliation or sales competition.
Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.
Portfolio intelligence
Therapeutic areas Broad portfolio view High-level clinical areas represented by this company’s current MedInfoBase portfolio.
Pharmacological detail
Drug classes More specific view More specific classes derived from the canonical generic and preserved curated classifications.
Portfolio leaders
Deepest brand families
Ranked by registered presentations · not sales
Price intelligence
Unit-price positioning vs equivalent products
Same generic + strength + form + unit basis
Below market median 2 100% of comparable products
Near market median 0 within ±5% of median
Above market median 0 0% of comparable products
Lowest-price equivalents 2 ties included
Company median price position
-50.9%
relative to the median unit price of like-for-like equivalent products.
Most competitively positioned examples Products with at least 3 market comparators
How MedInfoBase calculates price position Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.
Competitive landscape
Portfolio overlap Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.
Regulatory & price activity
Observed database signals
Registration numbers 3
Price-history records 3
Products with price history 0
Source records with multiple versions 0
Latest MedInfoBase verification 12 Aug 2026
Latest effective price date 12 Aug 2026
Latest source observation 12 Aug 2026
These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.
Sponsored company campaign area · advertising must be clearly disclosed
Complete company portfolio
Products and presentations
0 results
Brand Generic Strength Form Pack Registration Official price Unit price Price position
No matching products.
MedInfoBase company-intelligence methodology
This page is generated from MedInfoBase medicine, generic, company, price and DRAP-source records. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.
Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.
